化合物 DAPT|T6202

1篇文獻(xiàn)

價(jià)格	￥179	￥403	￥702
包裝	1mg	5mg	10mg

最小起訂量	1mg
發(fā)貨地	上海
更新日期	2025-03-12

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:化合物 DAPT	英文名稱:DAPT
CAS:208255-80-5	品牌: TargetMol
產(chǎn)地: 美國	保存條件: keep away from moisture \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
純度規(guī)格: 99.81%	產(chǎn)品類別: 抑制劑
貨號(hào): T6202

Product Introduction

Bioactivity

名稱	DAPT
描述	DAPT (LY-374973) is a γ-secretase inhibitor that inhibits total Aβ and Aβ42 (IC50=115/200 nM) and is orally active. DAPT is also a Notch inhibitor. DAPT induces cell differentiation, autophagy and apoptosis.
細(xì)胞實(shí)驗(yàn)	Human embryonic kidney cells, transfected with the gene for APP751 (HEK 293) were used for routine Ab reduction assays. The Ab peptides secreted from these cells have been characterized previously. Cells were plated in 96-well plates and allowed to adhere overnight in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum. For compound screening and dose±response testing, compounds were diluted from stock solutions in DMSO to yield a final concentration equal to 0.1% DMSO in media. Cells were pre-treated for 2 h at 378C with compounds, media were aspirated off and fresh compound solutions applied. After an additional 2-h treatment period, conditioned media were drawn off and analyzed by a sandwich ELISA (266±3D6) specific for total Ab. Reduction of Ab production was measured relative to control cells treated with 0.1% DMSO and expressed as percentage inhibition. Data from at least six doses in duplicate were fitted to a four-parameter logistical model using XLfit software in order to determine potency [1].
動(dòng)物實(shí)驗(yàn)	All studies were conducted with three- to four-month-old heterozygous PDAPP transgenic mice overexpressing the APPV717F a mutant form of the amyloid precursor protein. These animals have been previously shown to exhibit many of the neuropathological features of AD and to produce high levels of Ab in a regionally specific manner. Each treatment group (n=10) consisted of equal numbers of age-matched male and female animals that were fasted overnight prior to treatment. Both treatment and control groups were dosed at a volume of 10 mL/kg with compound formulated in corn oil, 5% (v/v) ethanol or vehicle alone. Tissues were processed and all Ab and APP measurements were made as described previously. After removal of the brain, the cortex from one hemisphere was homogenized, extracted with 5 M guanidine, 50 mM Tris ± pH 8.0, centrifuged, and the supernatant was used for Ab measurements. Cortex from the other hemisphere was snap frozen for analysis of compound levels. Ab levels were expressed as ng/g of wet tissue weight, and percentage reductions were calculated relative to the mean Ab level of tissue from vehicle-treated control animals. Data were analyzed with Mann± Whitney non-parametric statistics to assess significance [1].
體外活性	方法：卵巢腫瘤干細(xì)胞 (OCSC) HO8910 和 SKOV3 用 DAPT (1-20 μg/mL) 處理 24-72 h，使用 MTT 方法檢測(cè)細(xì)胞活力。結(jié)果：DAPT 孵育后，觀察到細(xì)胞自我更新和增殖顯著減少。DAPT 誘導(dǎo)對(duì) HO8910 和 SKOV3 OCSC 樣細(xì)胞的濃度依賴性抗增殖作用。[1] 方法：腫瘤細(xì)胞 GH3 和原代 GHoma 用 DAPT (20-100 nM) 處理 24 h，使用 Transwell 方法檢測(cè)細(xì)胞遷移情況。結(jié)果：DAPT 抑制 GH3 細(xì)胞和原代 GHoma 細(xì)胞遷移。[2]
體內(nèi)活性	方法：為檢測(cè)體內(nèi)抗腫瘤活性，將 DAPT (1-5 mg/kg) 腹腔注射給攜帶大鼠垂體腫瘤 GH3 的 athymic immune-deficient nude 小鼠模型，每天一天，持續(xù)十五天。結(jié)果：DAPT 治療顯著抑制了腫瘤生長。DAPT 治療的腫瘤中 Notch2 和 DLL3 的表達(dá)下調(diào)，DLL4 和 VEGF 表達(dá)沒有差異。[2] 方法：為研究對(duì)順鉑腎損傷的作用，將 DAPT (15 mg/kg in 20%Captisol) 腹腔注射給 cisplatin 引起腎損傷的 C57BL/6J 小鼠模型，每天一次，持續(xù)五天。結(jié)果：DAPT 減輕了順鉑誘導(dǎo)的腎小管損傷和腎小球?yàn)V過率的降低。Notch 信號(hào)通路可能是緩解順鉑化療相關(guān)腎臟并發(fā)癥的潛在治療靶點(diǎn)。[3]
存儲(chǔ)條件	keep away from moisture \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
溶解度	10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4.32 mg/mL (9.99 mM), Suspension. H2O : Insoluble DMSO : 43.2 mg/mL (99.89 mM), Sonication is recommended.
關(guān)鍵字	γ-secretase \| γ secretase(Aβ) \| β-amyloid peptide \| βAmyloid \| β Amyloid \| Notch \| LY374973 \| LY 374973 \| Inhibitor \| inhibit \| Gammasecretase \| Gamma secretase \| DAPT \| BetaAmyloid \| Beta Amyloid \| bAmyloid \| b Amyloid \| Aβ \| Autophagy \| Apoptosis \| Amyloid-β \| Abeta
相關(guān)產(chǎn)品	Naringin \| Guanidine hydrochloride \| L-Glutamic acid \| Gefitinib \| Cysteamine hydrochloride \| Alginic acid \| Dextran sulfate sodium salt (MW 5000) \| Hydroxychloroquine \| Stavudine \| L-Ascorbic acid sodium salt \| Paeonol \| Sodium 4-phenylbutyrate
相關(guān)庫	抑制劑庫 \| 神經(jīng)保護(hù)化合物庫 \| 經(jīng)典已知活性庫 \| 已知活性化合物庫 \| 細(xì)胞凋亡化合物庫 \| 抗衰老化合物庫 \| 臨床前化合物庫 \| 免疫/炎癥分子化合物庫 \| 神經(jīng)退行性疾病化合物庫 \| 口服活性化合物庫 \| 表型篩選靶點(diǎn)鑒定庫 \| 神經(jīng)元分化化合物庫

關(guān)鍵字： LY-374973|||GSI-IX|TargetMol

公司簡(jiǎn)介

上海陶術(shù)生物科技有限公司為美國Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國波士頓、德國慕尼黑的同事一起，為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部，化學(xué)事業(yè)部，生物事業(yè)部和新材料部。從虛擬篩選到實(shí)體化合物分子供應(yīng)；從商業(yè)化產(chǎn)品銷售到個(gè)性化定制合成；從對(duì)明確靶點(diǎn)的分子篩選到對(duì)明確分子的多靶點(diǎn)篩選，從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化，我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。經(jīng)過在中國市場(chǎng)五年的精心耕耘，我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商，為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩

成立日期	2013-04-18 （13年）	注冊(cè)資本	566.2651萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營行業(yè)	化學(xué)試劑,生物活性小分子	經(jīng)營模式	貿(mào)易,試劑,定制,服務(wù)

TargetMol中國（陶術(shù)生物）

VIP 13年

公司成立：13年
注冊(cè)資本：566.2651萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：小分子抑制劑，藥物篩選化合物庫，天然產(chǎn)物，活性分子化合物等
公司地址：上海市閘北區(qū)江場(chǎng)三路28號(hào)4樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

靶點(diǎn)化合物庫

￥5000

篩選化合物庫

￥100000

化合物 CI994|T1888

￥198